For years, people with obstructive sleep apnea (OSA) have asked whether a “sleep apnea pill” could replace CPAP machines or oral appliances. The investigational medication AD109—a combination of atomoxetine and aroxybutynin—has generated excitement after early studies suggested it may reduce apnea events in certain adults. But AD109 is not yet FDA-approved, and questions remain about … Continue reading AD109 “Sleep Apnea Pill”: What We Know, What We Don’t, and What Patients Should Expect